AJP - Lung Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol (March 2, 2007). doi:10.1152/ajplung.00446.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/6/L1467    most recent
00446.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tang, L.
Right arrow Articles by Fallon, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tang, L.
Right arrow Articles by Fallon, M.
Submitted on November 10, 2006
Accepted on February 22, 2007

Modulation of Pulmonary Endothelial Endothelin B Receptor Expression and Signaling: Implications for Experimental HPS

Liping Tang1, Bao Luo1, Rakesh Patel2, Yiqun Ling1, Junlan Zhang1, and Mike Fallon3*

1 Liver center, University of Alabama at Birmingham, Birmingham, Alabama, United States
2 Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States
3 Gastroenterology, U of Alabama Birmingham, Birmingham, Alabama, United States

* To whom correspondence should be addressed. E-mail: mfallon{at}uab.edu.

The hepatopulmonary syndrome (HPS) results from intrapulmonary vasodilation in the setting of cirrhosis and portal hypertension. In experimental HPS, pulmonary endothelial endothelin B (ETB) receptor overexpression and increased circulating endothelin-1 (ET-1) contribute to vasodilation through enhanced endothelial nitric oxide synthase (eNOS) derived nitric oxide (NO) production. In both experimental cirrhosis and pre-hepatic portal hypertension, ETB receptor overexpression correlates with increased vascular shear stress, a known modulator of ETB receptor expression. We investigated the mechanisms of pulmonary endothelial ETB receptor mediated eNOS activation by ET-1 in vitro and in vivo. The effect of shear stress on ETB receptor expression was assessed in rat pulmonary microvascular endothelial cells (RPMVECs). The consequences of ETB receptor overexpression on ET-1 dependent ETB receptor mediated eNOS activation were evaluated in RPMVECs and in pre-hepatic portal hypertensive animals exposed to exogenous ET-1. Laminar shear stress increased ETB receptor expression in RPMVECs without altering mRNA stability. Both shear mediated and targeted overexpression of the ETB receptor enhanced ET-1 mediated ETB receptor dependent eNOS activation in RPMVECs through Ca++ mediated signaling pathways and independent of Akt activation. In pre-hepatic portal hypertensive animals relative to control, ET-1 administration also activated eNOS independent of Akt activation and triggered HPS. These findings support that increased pulmonary microvascular endothelial ETB receptor expression modulates ET-1 mediated eNOS activation, independent of Akt and contributes to the development of HPS.




This article has been cited by other articles:


Home page
NEJMHome page
R. Rodriguez-Roisin and M. J. Krowka
Hepatopulmonary Syndrome -- A Liver-Induced Lung Vascular Disorder
N. Engl. J. Med., May 29, 2008; 358(22): 2378 - 2387.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.